These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 40148)

  • 1. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitroprusside on peritoneal dialysis clearances.
    Finkelstein FO; Yap P; Kliger AS
    Yale J Biol Med; 1980; 53(2):127-32. PubMed ID: 7395271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
    Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
    Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal clearances after 6--12 months on continuous ambulatory peritoneal dialysis.
    Rubin J; Arfania D; Nolph KD; Prowant B; Fruto L; Brown P; Moore H
    Trans Am Soc Artif Intern Organs; 1979; 25():104-9. PubMed ID: 524568
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
    Rubin J; Nolph K; Arfania D; Brown P; Prowant B
    Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvascular and clinical effects of altered peritoneal dialysis solutions.
    Miller FN; Nolph KD; Harris PD; Rubin J; Wiegman DL; Joshua IG; Twardowski ZJ; Ghods AJ
    Kidney Int; 1979 Jun; 15(6):630-9. PubMed ID: 37363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraperitoneal nitroprusside on peritoneal clearances in man with variations of dose, frequency of administration and dwell times.
    Nolph KD; Ghods AJ; Brown PA; Twardowski ZJ
    Nephron; 1979; 24(3):114-20. PubMed ID: 492421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced clearance with intraperitoneal nitroprusside in high flow recirculation peritoneal dialysis.
    Raja RM; Kramer MS; Rosenbaum JL
    Trans Am Soc Artif Intern Organs; 1978; 24():133-5. PubMed ID: 715988
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmented peritoneal mass transport with intraperitoneal nitroprusside.
    Hirszel P; Maher JF; Chamberlin M
    J Dial; 1978; 2(2):131-42. PubMed ID: 681579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pharmacologic agents on transperitoneal elimination of low-molecular compounds during peritoneal dialysis].
    Grzegorzewska A
    Pol Arch Med Wewn; 1989; 82(2-3):65-70. PubMed ID: 2638739
    [No Abstract]   [Full Text] [Related]  

  • 11. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. II. Intraperitoneal administration of sodium nitroprusside during intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1988; 45(6):485-90. PubMed ID: 3252349
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential intraperitoneal administration of nitroprusside in patients maintained on peritoneal dialysis.
    Riambau E; Lloveras J; Aubía J; Masramón J; García C; Orfila MA; Llorach M
    J Dial; 1980; 4(4):203-17. PubMed ID: 7204719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intraperitoneal vasodilators on peritoneal clearances.
    Nolph KD; Ghods AJ; Van Stone J; Brown PA
    Trans Am Soc Artif Intern Organs; 1976; 22():586-94. PubMed ID: 951875
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hypertonic dialysate and vasodilators on peritoneal dialysis clearances in the rat.
    Brown EA; Kliger AS; Goffinet J; Finkelstein FO
    Kidney Int; 1978 Apr; 13(4):271-7. PubMed ID: 651126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transperitoneal solute movement in children.
    Gruskin AB; Rosenblum H; Baluarte HJ; Morgenstern BZ; Polinsky MS; Perlman SA
    Kidney Int Suppl; 1983 Nov; 15():S95-100. PubMed ID: 6584681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal vascular reserve characterization through nitroprusside-induced modification of peritoneal mass transfer coefficients.
    Selgas R; Carmona AR; Martinez ME; Perez-Fontan M; Salinas M; Conesa J; Martinez Ara J; Sicilia LS
    Int J Artif Organs; 1985 Jul; 8(4):181-6. PubMed ID: 4055094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetate versus lactate in peritoneal dialysis solutions.
    Pedersen FB; Ryttov N; Deleuran P; Dragsholt C; Kildeberg P
    Nephron; 1985; 39(1):55-8. PubMed ID: 3969192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the effects of acetate and lactate in peritoneal dialysis solutions.
    Rossen B; Ladefoged J
    Scand J Urol Nephrol; 1982; 16(3):279-81. PubMed ID: 7163792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.